Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Top Cited Papers
- 10 June 2008
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 64 (1) , 60-70
- https://doi.org/10.1002/ana.21425
Abstract
Objective: TAR DNA‐binding protein of 43kDa (TDP‐43) is deposited as cytoplasmic and intranuclear inclusions in brains of patients with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD‐U) and amyotrophic lateral sclerosis (ALS). Previous studies reported that abnormal phosphorylation takes place in deposited TDP‐43. The aim of this study was to identify the phosphorylation sites and responsible kinases, and to clarify the pathological significance of phosphorylation of TDP‐43.Methods: We generated multiple antibodies specific to phosphorylated TDP‐43 by immunizing phosphopeptides of TDP‐43, and analyzed FTLD‐U and ALS brains by immunohistochemistry, immunoelectron microscopy, and immunoblots. In addition, we performed investigations aimed at identifying the responsible kinases, and we assessed the effects of phosphorylation on TDP‐43 oligomerization and fibrillization.Results: We identified multiple phosphorylation sites in carboxyl‐terminal regions of deposited TDP‐43. Phosphorylation‐specific antibodies stained more inclusions than antibodies to ubiquitin and, unlike existing commercially available anti–TDP‐43 antibodies, did not stain normal nuclei. Ultrastructurally, these antibodies labeled abnormal fibers of 15nm diameter and on immunoblots recognized hyperphosphorylated TDP‐43 at 45kDa, with additional 18 to 26kDa fragments in sarkosyl‐insoluble fractions from FTLD‐U and ALS brains. The phosphorylated epitopes were generated by casein kinase‐1 and ‐2, and phosphorylation led to increased oligomerization and fibrillization of TDP‐43.Interpretation: These results suggest that phosphorylated TDP‐43 is a major component of the inclusions, and that abnormal phosphorylation of TDP‐43 is a critical step in the pathogenesis of FTLD‐U and ALS. Phosphorylation‐specific antibodies will be powerful tools for the investigation of these disorders. Ann Neurol 2008Keywords
This publication has 49 references indexed in Scilit:
- Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human α‐synuclein: Implication for α‐synucleinopathiesFEBS Letters, 2007
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar DegenerationActa Neuropathologica, 2007
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosisBiochemical and Biophysical Research Communications, 2006
- Pathological Heterogeneity of Frontotemporal Lobar Degeneration with Ubiquitin-Positive Inclusions Delineated by Ubiquitin Immunohistochemistry and Novel Monoclonal AntibodiesThe American Journal of Pathology, 2006
- Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17Nature, 2006
- Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing proteinNature Genetics, 2004
- Identification of amino‐terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degenerationAnnals of Neurology, 2003
- Characterization of mAb AP422, a novel phosphorylation‐dependent monoclonal antibody against tau proteinFEBS Letters, 1996
- Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5Published by Wiley ,1993